Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Lynch syndrome
Lynch syndrome 2
An autosomal dominant hereditary neoplastic syndrome caused by pathogenic variants in the MLH1 mismatch repair gene. It is characterized by an increased risk of colorectal cancer in the absence of extensive polyposis, endometrial, ovarian, gastric, small intestinal, and urinary tract cancers, often occurring at younger ages.
This condition has no sub-types.